Cite
HARVARD Citation
Tabernero, J. et al. (n.d.). LBA-002Pembrolizumab with or without chemotherapy versus chemotherapy for first-line treatment of advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The Phase 3 KEYNOTE-062 Study. Annals of oncology. p. . [Online].